How many changes can you make to a protein?

Protein based medicines are a big field of research right now. In order to address how Synthetic Biology and AI are coming together to solve some really hard problems, we are joined by Dr Venkatesh Mysore, founder and CEO of Aikium Aikium Inc., a pioneering biotechnology startup based in Berkeley, California. Founded in 2022, Aikium is at the forefront of developing innovative protein therapeutics by harnessing breakthroughs in synthetic biology and artificial intelligence. The company specializes in creating a novel class of non-antibody scaffold proteins designed to target G Protein-Coupled Receptors (GPCRs), such as chemokine receptors, which play crucial roles in various diseases including oncology and neuro-inflammatory disorders. With a commitment to precise programmable binding and universal target coverage, Aikium aims to redefine therapeutic approaches and bring new treatments to life.
In this episode of "AI with Arun Show," we delve into the transformative work being done at Aikium and explore Dr. Mysore's insights on the future of protein biologics and the intersection of AI and biotechnology.

#ProteinEngineering #syntheticbiology #ai #llm #Aikium #DrVenkateshMysore #YottaML2 #transformer #crispr #ML #machinelearning #GPCR #biotechnology #BioTech #TechBio #medicine #oncology #neuroinflammation #drugdiscovery #DrugDiscovery
#Biotechnology
#SyntheticBiology
#AIinHealthcare
#ProteinTherapeutics
#GPCRs
#Aikium
#Innovation
#HealthTech
#Pharmaceuticals
#Startups
#Science
#Technology
#Healthcare
#ArtificialIntelligence

Видео How many changes can you make to a protein? канала AI with Arun Show